Genomic Responses of Mouse Synovial Fibroblasts During Tumor Necrosis Factor-Driven Arthritogenesis Greatly Mimic Those in Human Rheumatoid Arthritis-Reference-Cited by-同舟云学术

Genomic Responses of Mouse Synovial Fibroblasts During Tumor Necrosis Factor-Driven Arthritogenesis Greatly Mimic Those in Human Rheumatoid Arthritis

Published:2017-07-05 Issue:8 Volume:69 Page:1588-1600
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Ntougkos Evangelos¹,Chouvardas Panagiotis²,Roumelioti Fani²,Ospelt Caroline³,Frank-Bertoncelj Mojca³,Filer Andrew⁴,Buckley Christopher D.⁴,Gay Steffen³,Nikolaou Christoforos⁵,Kollias George²

Affiliation:

1. BSRC Alexander Fleming; Vari Greece

2. BSRC Alexander Fleming, Vari, Greece, and National and Kapodistrian University of Athens; Athens Greece

3. University Hospital of Zurich; Zurich Switzerland

4. University of Birmingham; Birmingham UK

5. BSRC Alexander Fleming, Vari, Greece, and University of Crete; Heraklion Greece

Funder

Innovative Medicines Initiative

General Secretariat for Research and Technology

Esperantic Studies Foundation

NSRF

European Research Council

IKY/Siemens

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Reference49 articles.

1. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis;Keffer;EMBO J,1991

2. Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases;Armaka;J Exp Med,2008

3. Fibroblast biology: role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis;Pap;Arthritis Res,2000

4. Synovial activation in rheumatoid arthritis;Ospelt;Front Biosci,2004

5. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis;Bartok;Immunol Rev,2010

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling Novel Drug Targets and Emerging Therapies for Rheumatoid Arthritis: A Comprehensive Review;ACS Pharmacology & Translational Science;2024-05-28

2. Discovery of the First‐in‐Class Inhibitors of Hypoxia Up‐Regulated Protein 1 (HYOU1) Suppressing Pathogenic Fibroblast Activation;Angewandte Chemie International Edition;2024-02-26

3. Discovery of the First‐in‐Class Inhibitors of Hypoxia Up‐Regulated Protein 1 (HYOU1) Suppressing Pathogenic Fibroblast Activation;Angewandte Chemie;2024-02-26

4. An update of murine models and their methodologies in immune-mediated joint damage and pain research;International Immunopharmacology;2024-02

5. Repurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritis;JCI Insight;2023-05-08